Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

606 Articles

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Jon C. Ogg | Aug 15, 2018 at 11:50 AM EDT

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors.…

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 27, 2018 at 11:20 AM EDT

Why AbbVie Earnings Were Not Enough for Investors

AbbVie released a better-than-expected quarterly report early on Friday, but shares retreated afterward.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 22, 2018 at 10:25 AM EDT

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger…

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

Jon C. Ogg | Jul 12, 2018 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Anadarko, Broadcom, CA, Chipotle, ConocoPhillips, GE, Honeywell, J&J, 3M, NetApp, Netflix and More

The top analyst upgrades, downgrades and other research calls from Thursday include AbbVie, Amazon.com, Anadarko, Broadcom, Chipotle Mexican Grill, ConocoPhiilips,…

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2018 at 10:15 AM EDT

AbbVie Slumps on Late-Stage Lymphoma Trial

AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.

Chris Lange | Jul 7, 2018 at 8:15 AM EDT

Major Biopharma Catalysts on July’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jun 15, 2018 at 10:07 AM EDT

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Lee Jackson | Jun 1, 2018 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines…

1 … 20 21 22 23 24 … 41

AbbVie : ABBV

All AbbVie Articles

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Why AbbVie Earnings Were Not Enough for Investors

Major Pharma Stocks Scare Off Short Sellers

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Anadarko, Broadcom, CA, Chipotle, ConocoPhillips, GE, Honeywell, J&J, 3M, NetApp, Netflix and More

Where Did Major Pharma Short Sellers Go?

AbbVie Slumps on Late-Stage Lymphoma Trial

Major Biopharma Catalysts on July’s FDA Calendar

Short Sellers Hike Bets in Major Pharma Stocks

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Major Pharmaceuticals Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Why Money Is Leaving Bitcoin for Hyperliquid

Former National Security Advisor Calls Iran’s $40 Billion Hormuz Toll Threat a “Blackmail Scheme” Against the Free Flow of Energy

You Aren’t Defined by Your Financial Mistakes: Dave Ramsey Tells a Caller to Cancel His Mother’s $18,000 Credit Card Immediately

You Aren't Defined by Your Financial Mistakes: Dave Ramsey Tells a Caller to Cancel His Mother's $18,000 Credit Card Immediately

Plumbers Retire Richer Than Their Bosses And Here's How the Pension Works

Why Money Is Leaving Bitcoin for Hyperliquid

Former National Security Advisor Calls Iran’s $40 Billion Hormuz Toll Threat a “Blackmail Scheme” Against the Free Flow of Energy

AbbVie : ABBV

All AbbVie Articles

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Short Sellers Hike Bets in Major Pharma Stocks

Why AbbVie Earnings Were Not Enough for Investors

Major Pharma Stocks Scare Off Short Sellers

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Anadarko, Broadcom, CA, Chipotle, ConocoPhillips, GE, Honeywell, J&J, 3M, NetApp, Netflix and More

Where Did Major Pharma Short Sellers Go?

AbbVie Slumps on Late-Stage Lymphoma Trial

Major Biopharma Catalysts on July’s FDA Calendar

Short Sellers Hike Bets in Major Pharma Stocks

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Major Pharmaceuticals Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Why Money Is Leaving Bitcoin for Hyperliquid

Former National Security Advisor Calls Iran’s $40 Billion Hormuz Toll Threat a “Blackmail Scheme” Against the Free Flow of Energy

You Aren’t Defined by Your Financial Mistakes: Dave Ramsey Tells a Caller to Cancel His Mother’s $18,000 Credit Card Immediately

Featured Reads

You Aren't Defined by Your Financial Mistakes: Dave Ramsey Tells a Caller to Cancel His Mother's $18,000 Credit Card Immediately

Plumbers Retire Richer Than Their Bosses And Here's How the Pension Works